Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02169726
Other study ID # 20139473
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 2013
Est. completion date December 2015

Study information

Verified date October 2022
Source University of California, Irvine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Back injuries are the most common reason people seeking for effective treatment. One of the most common treatments in sports medicine for muscular injuries is therapeutic ultrasound, which is designed to heat the injured tissue and increase the flow of blood to promote healing.


Description:

Researchers at Beckman Laser institute, using a technology developed at University of California, Irvine. The device call Diffuse Optical Spectroscopy, this device developed with harmless light that can measures and detect the change of blood flow, oxygen level, temperature and muscle tissue in lower back during therapeutic ultrasound therapy treatment. The researchers can provide information in real-time tissue change before, during, and after treatments that can determine the effectiveness of the treatment and speed up recovery time.


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male or Female over 18 years of age, - No back injuries, No plan treatment - Currently diagnose with back injuries, with plan treatment of therapeutic ultrasound Exclusion Criteria: - Minors - Obese - Pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Diffuse Optical Spectroscopy
Diffuse Optical Spectroscopy Imaging measure blood flow,oxygen, temperature in back muscle when they are treated with therapeutic ultrasound and can improve the treatment

Locations

Country Name City State
United States Beckman Laser Institute Irvine California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Irvine Beckman Laser Institute University of California Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Normal lower back muscle Diffuse Optical Spectroscopy Imaging measure blood flow,oxygen, temperature in back muscle when they are treated with therapeutic ultrasound and can improve the treatment 4 weeks